These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Induction of broadly neutralizing antibodies against measles virus mutants using a polyepitope vaccine strategy. Bouche FB, Steinmetz A, Yanagi Y, Muller CP. Vaccine; 2005 Mar 18; 23(17-18):2074-7. PubMed ID: 15755573 [Abstract] [Full Text] [Related]
25. Antibody against Chikungunya virus in wild primates in Southern Africa. McIntosh BM. S Afr J Med Sci; 1970 Dec 18; 35(3):65-74. PubMed ID: 4398581 [No Abstract] [Full Text] [Related]
26. [Chromatographic antibody determination with P32-labelled polio viruses and comparison of the results with the neutralization test]. Hils J, Böthig B. Dtsch Gesundheitsw; 1970 Jun 17; 25(24):1141-3. PubMed ID: 4323922 [No Abstract] [Full Text] [Related]
27. A comparison of micromethod and conventional tube method in detection of polio-neutralizing antibody. Moritsugu Y, Tantipalanonta A, Tagaya I. Jpn J Med Sci Biol; 1972 Feb 17; 25(1):43-6. PubMed ID: 4338980 [No Abstract] [Full Text] [Related]
28. Subacute sclerosing panencephalitis, measles, rabies and progressive multifocal leukoencephalopathy. Katz M, Koprowski H. Res Publ Assoc Res Nerv Ment Dis; 1971 Feb 17; 49():373-82. PubMed ID: 5000224 [No Abstract] [Full Text] [Related]
30. Level of antibodies in human gamma-globulin preparations. Stárek M, Mazácek M, Kyselová M, Babková H. Prog Immunobiol Stand; 1970 Feb 17; 4():126-8. PubMed ID: 4098253 [No Abstract] [Full Text] [Related]
31. [Current problems in measles. II. Measles vaccines--recent progress]. Ciufecu E. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984 Feb 17; 29(3):259-78. PubMed ID: 6438773 [No Abstract] [Full Text] [Related]
32. [Studies on determination of poliovirus neutralizing antibodies by air dried filter paper disc method]. Watanabe Y. Kumamoto Igakkai Zasshi; 1970 Apr 25; 44(4):251-85. PubMed ID: 4317108 [No Abstract] [Full Text] [Related]
33. Production and potential use of monoclonal antibodies against polio viruses. Osterhaus AD, van Wezel AL, van Steenis G, Hazendonk AG, Drost G. Dev Biol Stand; 1981 Apr 25; 50():221-8. PubMed ID: 6281107 [Abstract] [Full Text] [Related]
34. A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles. Polack FP, Hoffman SJ, Crujeiras G, Griffin DE. Nat Med; 2003 Sep 25; 9(9):1209-13. PubMed ID: 12925847 [Abstract] [Full Text] [Related]
35. Immune response of pups to modified live-virus canine distemper-measles vaccine. Brown AL, Vitamvas JA, Merry DL, Beckenhauer WH. Am J Vet Res; 1972 Jul 25; 33(7):1447-56. PubMed ID: 5039517 [No Abstract] [Full Text] [Related]
37. Clinical and immune response of alien hosts to inoculation with measles, rinderpest, and canine distemper viruses. DeLay PD, Stone SS, Karzon DT, Katz S, Enders J. Am J Vet Res; 1965 Nov 25; 26(115):1359-73. PubMed ID: 4956660 [No Abstract] [Full Text] [Related]
38. Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies. Ong HT, Hasegawa K, Dietz AB, Russell SJ, Peng KW. Gene Ther; 2007 Feb 25; 14(4):324-33. PubMed ID: 17051248 [Abstract] [Full Text] [Related]